PARK2 Antibody - Cat. #: CSB-PA076233

SKU: CSB-PA076233

Size :100ul

Clone Number:

Aliases:AR JP antibody; E3 ubiquitin ligase antibody; E3 ubiquitin protein ligase parkin antibody; E3 ubiquitin-protein ligase parkin antibody; FRA6E antibody; LPRS 2 antibody; LPRS2 antibody; PARK 2 antibody; Park2 antibody; Parkin 2 antibody; Parkinson disease (autosomal recessive juvenile) 2 antibody; Parkinson disease (autosomal recessive; juvenile) 2; parkin antibody; Parkinson disease protein 2 antibody; Parkinson juvenile disease protein 2 antibody; Parkinson protein 2 E3 ubiquitin protein ligase antibody; Parkinson protein 2; E3 ubiquitin protein ligase (parkin) antibody; PDJ antibody; PRKN 2 antibody; PRKN antibody; PRKN2 antibody; PRKN2_HUMAN antibody; Ubiquitin E3 ligase PRKN antibody

Product Type:Polyclonal Antibody

Immunogen Species:Homo sapiens (Human)

UniProt ID:O60260

Immunogen:Synthesized peptide derived from Human Parkin antibody.

Raised in:Rabbit

Species Reactivity:Human, Mouse, Rat

Tested Applications:ELISA, WB, IHC; WB:1:500-1:3000, IHC:1:50-1:100

Background:Functions within a multiprotein E3 ubiquitin ligase complex, catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins, such as BCL2, SYT11, CCNE1, GPR37, STUB1, a 22 kDa O-linked glycosylated isoform ofSNCAIP, SEPT5, ZNF746 and AIMP2. Mediates monoubiquitination as well as 'Lys-48'-linked and 'Lys-63'-linked polyubiquitination of substrates depending on the context. Participates in the removal and/or detoxification of abnormally folded or damaged protein by mediating 'Lys-63'-linked polyubiquitination of misfolded proteins such as PARK7: 'Lys-63'-linked polyubiquitinated misfolded proteins are then recognized by HDAC6, leading to their recruitment to aggresomes, followed by degradation. Mediates 'Lys-63'-linked polyubiquitination of SNCAIP, possibly playing a role in Lewy-body formation. Mediates monoubiquitination of BCL2, thereby acting as a positive regulator of autophagy. Promotes the autophagic degradation of dysfunctional depolarized mitochondria (mitophagy), potentially by the ubiquitination of mitochondrial proteins. Mediates 'Lys-48'-linked polyubiquitination of ZNF746, followed by degradation of ZNF746 by the proteasome; possibly playing a role in the regulation of neuron death. Limits the production of reactive oxygen species (ROS). Regulates cyclin-E during neuronal apoptosis. In collaboration with CHPF isoform 2, may enhance cell viability and protect cells from oxidative stress. Independently of its ubiquitin ligase activity, protects from apoptosis by the transcriptional repression of p53/TP53. May protect neurons against alpha synuclein toxicity, proteasomal dysfunction, GPR37 accumulation, and kainate-induced excitotoxicity. May play a role in controlling neurotransmitter trafficking at the presynaptic terminal and in calcium-dependent exocytosis. May represent a tumor suppressor gene.

Fang Yang, J. Biol. Chem., Apr 2005; 280: 17154 - 17162.
Yukiko Kuroda, Hum. Mol. Genet., Mar 2006; 15: 883 - 895.
Iris H. Henn, J. Neurosci., Feb 2007; 27: 1868 - 1878.
Monica Joch, Mol. Biol. Cell, Jun 2007; 10.1091/mbc.E05-11-1027.

Clonality:Polyclonal

Isotype:IgG

Purification Method:The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Conjugate:Non-conjugated

Buffer:Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Form:liquid

Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Names:PRKN

Research Areas:Neuroscience;Cell biology;Metabolism